Clinical Research Detail Title Of Study A study to determine the safety and activity of a novel oral agent, AV-951, in patients with kidney cancer To determine the safety and efficacy of AV-951 for the treatment in patients with Renal cell carcinoma. Disease Condition Patients with Renal Cell Carcinoma Phase of Trial Phase-2 Discipline Oncology Start date of Trial 12/31/2007 Closing Date of Trial 2/28/2009 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]